Featured News
-
ACLA Statement in Response to U.S. Court of Appeals Ruling in ACLA v. Azar
Court of Appeals Says ACLA is Entitled to Challenge HHS’s Harmful Regulatory Overreach Washington, D.C. — In response to today’s ruling from the U.S. Court of Appeals for the District of Columbia in favor of the American Clinical Laboratory Association (ACLA) in its lawsuit against the Department of Health and Human Services (HHS), ACLA President Julie Khani issued the following statement: “We strongly commend the CourtContinue Reading »... -
National Health Organizations Call on Congressional Leaders to Delay Flawed Reporting Process Jeopardizing Seniors’ Access to Laboratory Care
LAB Act would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. – With 53 million Americans facing steep year-over-year cuts to vital clinical diagnostics, 26 national groups representing patient, provider, diagnostic and laboratory organizations called on Congressional leadership to delay a flawed data collection process that continues to erode Medicare lab benefits for the country’s mostContinue Reading »... -
Op-Ed: If Washington takes a short-sighted view, seniors will pay the price
This week, ACLA President Julie Khani published an op-ed in The Hill, responding to a troubling recent proposal by Roger Klein to disregard private payor data and instead impose a spending cap for some tests. As Khani points out, “Such a plan would further erode PAMA’s clear goal of moving to a market-based system in Medicare and would undermine the assurances of a predictableContinue Reading »... -
Statement of The American Clinical Laboratory Association on Automated Chemistry Test Panels Under PAMA
... -
Reps. Peters, Bilirakis, Pascrell, Schrader, Holding and Hudson Introduce Bipartisan Legislation to Protect Seniors’ Lab Benefits, Improve Data Reporting Under PAMA
LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. — With 53 million Americans facing steep year-over-year cuts to vital clinical diagnostics, the American Clinical Laboratory Association (ACLA), AdvaMed, the National Independent Laboratory Association (NILA) and the Point of Care Testing Association applaud new bipartisan legislation introduced to address a flawedContinue Reading »... -
CDC, Private Sector Laboratory Partners Build on Cross-Sector Collaboration Related to Emergency Preparation & Response
ATLANTA, G.A. – The Centers for Disease Control and Prevention (CDC) led a tabletop exercise with multiple partners to strengthen diagnostic laboratory surge testing capacity during an emergency response. The purpose of the exercise was to assess the utility of a newly created CDC Emergency Operations Center (EOC) Laboratory Task Force Guide, and to review the processes for commercial clinical laboratories to provide diagnosticContinue Reading »... -
During emergencies and in everyday life, labs support public health goals
Clinical laboratory diagnostics advance public health goals in communities across the country every single day. For patients facing diabetes, heart disease, liver disease, kidney disease, prostate and colon cancers, anemia, infections and countless other common health conditions, routine lab tests are often the starting point for monitoring, diagnosing and treating disease. But our role in public health doesn’t stop there. Commercial labs have aContinue Reading »... -
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers reiterated the urgent need for Congressional action on a modernized regulatory framework for clinical laboratory diagnostics. Patients have yet to benefit from groundbreaking clinical diagnostics that monitor and support treatment for complex and rareContinue Reading »... -
New analysis challenges GAO Report’s assumptions on lab billing
A new analysis from Braid-Forbes Health Research exposes the Government Accountability Office’s (GAO) flawed assumptions about lab billing practices by presenting survey data on more than 20 million actual clinical laboratory claims. Braid-Forbes’ analysis of publicly available data demonstrates that the GAO’s claim – that labs are receiving “excess payments” by charging Medicare for individual component tests in greater numbers rather than charging reducedContinue Reading »... -
ACLA Elects 2019-2020 Board of Directors
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2019-2020. Douglas M. VanOort, Chairman and CEO of NeoGenomics Laboratories will take on a new leadership role as ACLA Board Chair, replacing Dr. Curtis Hanson of Mayo Clinic Laboratories. Jerry Hussong, CEO of Sonic Healthcare USA was elected Vice Chair and John Kolozsvary, CEOContinue Reading »...
